ARCHIVES

Imbruvica Improves PFS, OS In Phase III CLL Study

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Study Confirms Cancer Risk Increase Due To Combined HRT

January 31, 2003

Foundation For COG Is New Name Of NCCF.

October 19, 2001

Kennedy To Propose NIH Construction Authority, Legislation Using IOM Study Recommendations

January 13, 1989

‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address

January 13, 1995

Marker Research Plans Described; NCAB May Consider Asking For Special Study Section For Those Grants

March 11, 1983

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001